Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors.
about
Thermal protection with 5% dextrose solution blanket during radiofrequency ablation.Pyogenic liver abscess: differences in etiology and treatment in Southeast Asia and Central Europe.Ultrasound guided aspiration of hydrosalpinx fluid versus salpingectomy in the management of patients with ultrasound visible hydrosalpinx undergoing IVF-ET: a randomized controlled trial.Prevention and management of infectious complications of percutaneous interventions.Prophylactic antibiotic guidelines in modern interventional radiology practice.Liver Abscess Formation Following Transarterial Chemoembolization: Clinical Features, Risk Factors, Bacteria Spectrum, and Percutaneous Catheter Drainage.Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients.Incidence and Risk Factors for Liver Abscess After Thermal Ablation of Liver Neoplasm.Recent advances of radiofrequency ablation for early hepatocellular carcinoma.Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms.Various complications of percutaneous radiofrequency ablation for hepatic tumors: radiologic findings and technical tips.Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors.Complications of image-guided thermal ablation of liver and kidney neoplasms.Modern role of clinical ultrasound in liver abscess and echinococcosis.Evaluation of infectious complications following percutaneous liver ablation in patients with bilioenteric anastomoses.Preventing intrahepatic infection after ablation of liver tumours in biliary-enteric anastomosis patients.High Rate of Organ/Space Surgical Site Infection After Hepatectomy with Preexisting Bilioenteric Anastomosis.Is Antibiotic Prophylaxis for Percutaneous Radiofrequency Ablation (RFA) of Primary Liver Tumors Necessary? Results From a Single-Center Experience.Use of Prophylactic Antibiotics to Prevent Abscess Formation Following Hepatic Ablation in Patients with Prior Enterobiliary Manipulation.Case report. Spontaneous cholecystocolic fistula and locoregional liver tumour ablation: a cautionary tale.Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft.Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion.Ante-situm hepatic resection for tumors involving the confluence of hepatic veins and IVC.
P2860
Q30494028-ACC041B0-B61E-46A7-834D-8168B7A030AAQ33879425-A5E52E8F-646D-4884-9D66-DEE5903205C0Q35190271-2EFB59D3-945E-4158-B53C-D4FF201E1938Q35662040-8353EF31-F1D7-473E-8589-8161CA019355Q35882926-5D0FF043-4536-47D7-8E97-C0C2D4731381Q37206460-77C243CF-1B26-48F1-B5F4-74C699241996Q37214610-30FF815E-2A5A-4D0C-B49C-FB15013BAF7EQ37246463-4AF2152E-5D5C-44CA-8C49-8E1CEBB7199AQ37825656-8721FA6D-D59C-4CBB-ABDF-AF307822D996Q37995052-45C2635C-A149-4494-89B5-78E255EC11DDQ38006943-DA6589D8-89FE-4A73-82B3-F5B55CFC39CAQ38166333-848981DB-80F9-4BEF-96BC-63DDB92E99BBQ38199680-53AF0F89-52B2-48B9-AFF6-D44D73EB4010Q38232561-9F52FF82-CB6E-4605-A565-4DC106775983Q38894160-54183358-0D1F-42FB-AD3B-8A17EFCCCCB9Q39098370-9B1B6212-511A-4795-8C21-FEF6AC42703AQ40055654-5EA45BF6-C5A3-44F1-BCD2-15916EEEFBBCQ40908198-57B50CAD-8D59-44E5-B6BF-24F3B7B9CA97Q41665232-DA2AF9FB-7DDE-4CCC-9FC3-28F35A2176FBQ42002409-1688086B-0687-4F92-B982-B810C5864BDFQ42419300-C1B0545A-02ED-423A-980C-3883DD09A1B4Q48514721-7F975FCD-BBCA-4615-A941-43F1B54AD35EQ51011499-CD2987E2-8432-4B06-AFAB-31EF819573A0Q53156799-A97505EF-4C25-4F34-81FC-9D5519E12762
P2860
Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cholangitis and liver abscess ...... s: incidence and risk factors.
@ast
Cholangitis and liver abscess ...... s: incidence and risk factors.
@en
type
label
Cholangitis and liver abscess ...... s: incidence and risk factors.
@ast
Cholangitis and liver abscess ...... s: incidence and risk factors.
@en
prefLabel
Cholangitis and liver abscess ...... s: incidence and risk factors.
@ast
Cholangitis and liver abscess ...... s: incidence and risk factors.
@en
P2093
P1476
Cholangitis and liver abscess ...... s: incidence and risk factors.
@en
P2093
Etsuro Hatano
Hiroaki Terajima
Masahiro Hiraoka
Naritaka Yamamoto
Takeshi Kubo
Toshiya Shibata
Toyomichi Shibata
Yoji Maetani
P304
P356
10.1097/01.RVI.0000099532.29957.4F
P577
2003-12-01T00:00:00Z